These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9303507)

  • 21. Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern.
    Jazayeri SM; Dornan ES; Boner W; Fattovich G; Hadziyannis S; Carman WF
    J Infect Dis; 2004 May; 189(9):1634-45. PubMed ID: 15116300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
    Zhang K; Imazeki F; Fukai K; Arai M; Kanda T; Mikata R; Yokosuka O
    J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The detection of serum hepatitis B virus Pre-S1 antigen and its relationship with HBeAg/anti-HBe and HBV DNA by polymerase chain reaction].
    Xu B; Yao G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):117-20. PubMed ID: 15619813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamics of HBV-DNA level in acute hepatitis B].
    Zhao H; Cao JH; Tian GS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):159-61. PubMed ID: 12870000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen.
    Shinji T; Koide N; Hanafusa T; Hada H; Oka T; Takayama N; Shiraha H; Nakamura M; Ujike K; Yumoto Y; Tsuji T
    Hepatogastroenterology; 1998; 45(20):500-2. PubMed ID: 9638436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B.
    Oketani M; Oketani K; Xiaohong C; Arima T
    J Med Virol; 1999 Aug; 58(4):332-7. PubMed ID: 10421398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanisms of hepatitis B e antigen seroconversion from the aspect of viral mutation].
    Torii N; Hasegawa K; Oomori K; Shiratori K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():93-7. PubMed ID: 15453294
    [No Abstract]   [Full Text] [Related]  

  • 30. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of repeated seroconversion to HBe antibody due to co-infection with Mutant- and wild-type hepatitis B virus clones].
    Yukimasa N; Matsuda R; Yoneyama K; Takagi Y; Gomi K
    Rinsho Byori; 2006 Jan; 54(1):31-5. PubMed ID: 16499227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential analyses of the mutations in the core upstream and precore regions of hepatitis B virus genome in anti-HBe positive-carriers developing acute exacerbation.
    Nishizono A; Kohno K; Takita-Sonoda Y; Hiraga M; Terao H; Fujioka T; Nasu M; Mifune K
    J Med Virol; 1997 Nov; 53(3):266-72. PubMed ID: 9365894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history of hepatitis B in perinatally infected carriers.
    Boxall EH; Sira J; Standish RA; Davies P; Sleight E; Dhillon AP; Scheuer PJ; Kelly DA
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F456-60. PubMed ID: 15321970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays.
    Baumeister MA; Medina-Selby A; Coit D; Nguyen S; George-Nascimento C; Gyenes A; Valenzuela P; Kuo G; Chien DY
    J Med Virol; 2000 Mar; 60(3):256-63. PubMed ID: 10630956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of hepatitis Be antigen and anti-HBE in adults in Benin City.
    Abiodun PO; Olomu A; Okolo SN; Obasohan A; Freeman O
    West Afr J Med; 1994; 13(3):171-4. PubMed ID: 7841109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
    Cabrerizo M; Bartolomé J; Iñigo ER; López-Alcorocho JM; Cotonat T; Carreño V
    J Med Virol; 1998 Dec; 56(4):294-9. PubMed ID: 9829632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.